tiprankstipranks
Erytech Pharma SA (ERYP)
NASDAQ:ERYP

Erytech Pharma SA (ERYP) Technical Analysis

0 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
4Neutral
13Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Erytech Pharma SA’s (ERYP) Moving Averages Convergence Divergence (MACD) indicator is -0.03, suggesting Erytech Pharma SA is a Buy.
Erytech Pharma SA’s (ERYP) 20-Day exponential moving average is 0.81, while Erytech Pharma SA’s (ERYP) share price is $0.78, making it a Sell.
Erytech Pharma SA’s (ERYP) 50-Day exponential moving average is 0.84, while Erytech Pharma SA’s (ERYP) share price is $0.78, making it a Sell.

Erytech Pharma SA (ERYP) Pivot Points

Apr 27, 2024, 03:31 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.42
0.51
0.60
0.69
0.78
0.87
0.97
Fibonacci
0.51
0.58
0.62
0.69
0.76
0.80
0.87
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Erytech Pharma SA (ERYP) Moving Averages

Apr 27, 2024, 03:31 AM
Period
Simple
Exponential
MA5
0.76Sell
0.76Sell
MA10
0.79Sell
0.78Sell
MA20
0.80Sell
0.81Sell
MA50
0.87Sell
0.84Sell
MA100
0.86Sell
0.84Sell
MA200
0.74Buy
0.81Sell
Erytech Pharma SA’s (ERYP) 10-Day exponential moving average is 0.78, while Erytech Pharma SA’s (ERYP) share price is $0.78, making it a Sell.
Erytech Pharma SA’s (ERYP) 100-Day exponential moving average is 0.84, while Erytech Pharma SA’s (ERYP) share price is $0.78, making it a Sell.
Erytech Pharma SA’s (ERYP) stock price is $0.78 and Erytech Pharma SA’s (ERYP) 50-day simple moving average is 0.87, creating a Sell signal.
Erytech Pharma SA’s (ERYP) stock price is $0.78 and Erytech Pharma SA’s (ERYP) 100-day simple moving average is 0.86, creating a Sell signal.
Erytech Pharma SA’s (ERYP) stock price is $0.78 and Erytech Pharma SA’s (ERYP) 200-day simple moving average is 0.74, creating a Buy signal.

Erytech Pharma SA (ERYP) Technical Indicators

Apr 27, 2024, 03:31 AM
Name
Value
Implied Action
RSI (14)
42.61
Neutral
STOCH (9,6)
40.66
Neutral
STOCHRSI (14)
40.66
Neutral
MACD (12,26)
-0.03
Buy
ADX (14)
10.08
Buy
Williams %R
-50.78
Buy
CCI (14)
-177.15
Buy
ATR (14)
0.09
-
Ultimate Oscillator
47.27
Neutral
ROC
-10.71
Sell
Erytech Pharma SA’s (ERYP) Relative Strength Index (RSI) is 42.61, creating a Neutral signal.
Erytech Pharma SA’s (ERYP) Trend Strength Indicator (ADX) is 10.08, creating a Buy signal.
Erytech Pharma SA’s (ERYP) Commodity Channel Index (CCI) is -177.15, creating a Buy signal.
Erytech Pharma SA’s (ERYP) Price Rate of Change (ROC) is -10.71, creating a Sell signal.

FAQ

Is ERYP a Buy, Hold, or Sell?
Based on ERYP’s technical indicators, ERYP is a Sell.
    What is ERYP’s RSI (14)?
    ERYP’s RSI (14) is 42.61, which suggests ERYP is a Neutral.
      What is ERYP’s MACD?
      ERYP’s MACD is -0.03, which suggests ERYP is a Buy.
        What is ERYP’s 5-day moving average?
        ERYP’s 5-day moving average is 0.76, which suggests ERYP is a Sell.
          What is ERYP’s 20-day moving average?
          ERYP 20-day moving average is 0.80, which suggests ERYP is a Sell.
            What is ERYP’s 50-day moving average?
            ERYP’s 50-day moving average is 0.87, which suggests ERYP is a Sell.
              What is ERYP’s 200-day moving average?
              ERYP’s 200-day moving average is 0.74, which suggests ERYP is a Buy.
                What is ERYP’s Williams % R (14)?
                ERYP’s Williams % R (14) is -50.78, which suggests ERYP is a Buy.
                  What is ERYP’s CCI (14)?
                  ERYP’s CCI (14) is -177.15, which suggests ERYP is a Buy.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis